Navigation Links
Olympus Introduces the World's Only Articulating HD 3D Laparoscopic Surgical Video System
Date:4/9/2013

CENTER VALLEY, Pa., April 9, 2013 /PRNewswire/ -- Olympus, a precision technology leader in designing and delivering innovative solutions in Medical and Surgical Products, among other core businesses, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Articulating HD 3D Laparoscopic Surgical Video System. 

(Photo:  http://photos.prnewswire.com/prnh/20130409/PH89763 )

The Olympus Articulating HD 3D Laparoscopic Surgical Video System delivers value to surgeons and patients by reducing surgical errors and improving the speed, accuracy and precision of surgical tasks such as dissection, grasping and suturing when compared with traditional 2D surgical systems, based on internal Olympus testing conducted using a simulated surgical model. This is accomplished by restoring natural 3D vision and depth perception when performing laparoscopic procedures and is independent of a surgeon's skill level.

"The Olympus HD 3D system is ideal for suturing, accurately identifying tissue planes and other precision surgical tasks that are required in my laparoscopic surgical cases," said Dr. Marcos Michellotti , Assistant Professor of Surgery at Loma Linda University Health System in Loma Linda, California. "In addition, the articulating design enables me to obtain the critical view of anatomical structures in HD 3D without losing the important visual horizon. This is not possible with traditional fixed angle laparoscopes."

Another significant advantage of the new Olympus HD 3D video platform is its availability as a module that can be easily added to an existing Olympus EVIS EXERA III Universal Imaging System. The modular design reduces the investment necessary to add 3D capability, and allows the surgeon to choose either 2D or 3D visualization from the surgical field. This helps to reduce capital investments and simplify asset management and training.                              

"The Olympus HD 3D System brings value to those surgeons that need the precision, resolution, and depth perception of 3D without the substantial capital investment and annual maintenance expenses associated with alternatives such as robotic technology," said Luke Calcraft , President of the Medical Systems Group at Olympus Corporation of the Americas. "We are leading the way with new innovations to help our customers realize the clinical efficacy and cost effectiveness required under Accountable Care."

Olympus is a pioneer of minimally invasive surgery (Laparoscopy), a modern technique in which an operation in the abdomen is performed through small incisions as compared to larger incisions needed in traditional surgical procedures. This surgical approach addresses the key requirements of Healthcare Reform:

  • Increased Quality of Care – Minimally invasive surgery provides better clinical outcomes than traditional "open" surgery.
  • Decreased Costs – Numerous industry and clinical studies have demonstrated that minimally invasive surgery provides significant cost savings when compared to a robotic surgical approach.*
  • Enhanced Patient Satisfaction – Minimally invasive surgery provides less scarring, shorter hospital stays and faster recovery than traditional "open" surgery.

The Olympus Articulating HD 3D Laparoscopic Surgical Video System will be showcased at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) 2013 Annual Meeting to be held April 17-20 in Baltimore, MD.  Surgeons are invited to visit booth #111 and experience the benefits of the HD 3D technology. 

For more information or to evaluate the HD 3D Laparoscopic Surgical Video System, please contact your Olympus representative or call 800-548-5515.

*Data on file. 

About Olympus Medical Systems Group

Olympus Medical Systems Group, a division of global technology leader Olympus, develops solutions for healthcare professionals that help improve clinical outcomes, reduce overall costs and enhance quality of life for their patients. By enabling less invasive procedures, innovative diagnostic and therapeutic endoscopy, and early stage lung cancer evaluation and treatments, Olympus is transforming the future of healthcare.

For more information visit Olympus at www.olympusamerica.com.

The Olympus ENDOEYE FLEX 3D is the world's only Articulating HD 3D Video laparoscope.


'/>"/>
SOURCE Olympus Medical Systems Group
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Olympus Biotech International Ltd and BonAlive Biomaterials Ltd Announce Distribution Agreement
2. Olympus Introduces the Worlds First and Only Monopolar, Disposable Tonsil Adenoid Debrider (DTAD)
3. Mission Pharmacal Company Introduces Prednisolone Sodium Phosphate Oral Solution 25mg/5mL
4. Mitek Sports Medicine Introduces New Interference Screw Design For Faster, Easier Insertion
5. Ariosa Diagnostics Introduces Y-Chromosome Analysis Test Option
6. Endeavor Power Corporation Introduces Its Proprietary FDA Cleared Target System Platform Technology
7. Leviton Introduces Medical-Grade Power Strips for Use in Patient-Care Areas
8. Omnetics Introduces New PZN Connectors as Demand Increases for High Reliability and Portability Offered by Miniature Connector Systems
9. Kimberly-Clark Introduces Revolutionary CERVICOOL Cooled Radiofrequency System for Cervical Joint Pain
10. Kimberly-Clark Introduces Revolutionary CERVICOOL Cooled Radiofrequencey System for Cervical Joint Pain
11. Faxitron Introduces New Surgical Specimen Container
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... SAN DIEGO , Feb. 10, 2016 ... viral gene therapy manufacturing, and Renova™ Therapeutics, a biopharmaceutical ... and other chronic diseases, have entered into a Manufacturing ... produce cGMP-grade RT-100 (Ad5.hAC6) Drug Product for use in ... --> This relationship will leverage Lonza,s ...
(Date:2/10/2016)... Calif. , Feb. 10, 2016  Rich Pharmaceuticals, ... today announced a 1-for-100 reverse split of its issued ... opening of trading on Thursday, February 11, 2016. The ... under new CUSIP number 76303T308 and temporary ticker symbol ... commence trading under the ticker symbol (RCHA).  ...
(Date:2/10/2016)... , Feb. 10, 2016  The ALS Association, in partnership ... Grand Challenge to generate a biomarker to track TDP43 aggregation. ... up to a $1 million investment. ... disease that affects nerve cells in the brain and the ... initiate and control muscle movement, which often leads to total ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... February 10, 2016 , ... Ongoing news of the ... Care Association™ (ALCA) to conduct a survey that takes a closer look at cases ... illustrates the prevalence and causes of TBI among the aging population, and identifies the ...
(Date:2/10/2016)... ... 10, 2016 , ... AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company ... and full year ended December 31, 2015 on Monday, February 29, 2016 after the ... investment community following the release at 4:30 PM ET. Investors interested in participating by ...
(Date:2/10/2016)... ... 2016 , ... For additional information contact Phyllis Strupp 480-488-5858 , Brain improves ... The Ultimate Guide to Brain Training" by award-winning author Phyllis Strupp explains ... is March 16, 2016. A free review copy is available to the media ...
(Date:2/10/2016)... ... February 10, 2016 , ... IDEX Health & Science, LLC ... steel (PLS) columns combine the strength of traditional stainless steel with the chemical ... samples while operating at ultra-high pressures of 20,000 psi. The higher operating pressures ...
(Date:2/10/2016)... , ... February 10, 2016 , ... The recreational use ... enthusiasts in the state still face a lot of restrictions as to where they ... intended for private, personal use” and that cannabis “may not be consumed openly or ...
Breaking Medicine News(10 mins):